GERON — 1789597

Toolbar

Details

Application number

1789597

Registration number

TMA1091558

Type(s)

Word

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2016-06-30

Registered

2021-01-13

Registration Expiry Date

2031-01-13

Registered Owner

Geron Corporation
919 E. Hillsdale Blvd., Suite 250
Foster City, CA 94404
UNITED STATES OF AMERICA

Agent

SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2

Documents

Index headings

  • GERON

Goods (Nice class & Statement)

1
(1) Chemicals for performing enzymatic and chemi-enzymatic reactions in the field of pharmaceuticals; Chemicals for performing scientific analysis in the field of pharmaceuticals; diagnostic reagents for medical-scientific research use; cell lines for screening and development of pharmaceuticals; cell growth media for growing cells for use in scientific research; combinatorial chemistry and gene sequence libraries for assessing the condition of cells, drug screening, and the development of pharmaceuticals; clones and cloning tools, namely, plasmids, vectors, deoxyribonucleic acid DNA and ribonucleic acid RNA, proteins, enzymes, catalysts and substrates, for scientific and research use; kits for scientific and for research use comprised of reagents, substrates, enzymes and assays.
5
(2) Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for the treatment, diagnosis and prophylaxis of human diseases, disorders and conditions, namely, diabetes, arthritis, osteoporosis, bone fractures, cardiovascular, neuronal and nervous systems namely, Alzheimer's, Huntington's Disease, cerebral palsy, encephalitis, epilepsy, and Parkinson's disease, brain injury, spinal cord injury, seizure disorders, central nervous system infections, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, central nervous system movement disorders, ocular motility disorders, and spinal cord diseases, and pharmaceutical preparations for wounds; diagnostic reagents for medical diagnostic use and medical laboratory use.
5
(3) Therapeutic, diagnostic, and prophylactic preparations, pharmaceutical products and agents for the treatment, diagnosis and prophylaxis of human diseases, disorders and conditions, namely, cancers, and blood disorders and conditions.

Services (Nice class & Statement)

42
(1) Scientific research and development of preparations, agents and biotechnology for the treatment, diagnosis and prophylaxis of human diseases, disorders and conditions, namely cancer, diabetes, arthritis, osteoporosis, bone fractures and wound healing, and diseases, disorders and conditions of the cardiovascular, hematological, neuronal and nervous systems; scientific research and development of cosmetics, sundries and nutraceuticals; Providing scientific information in connection with, and for the treatments of, cancers, blood disorders and conditions, and blood diseases.
44
(2) Providing medical information in connection with, and for the treatments of, cancers, blood disorders and conditions, and blood diseases.

Claims

  • Used in UNITED STATES OF AMERICA
  • Registered in or for UNITED STATES OF AMERICA on July 04, 2006, under No. 3,113,186 on goods (3) and on services
  • Proposed Use in CANADA on goods (1), (2)
  • Filed in UNITED STATES OF AMERICA on December 16, 2015, under No. 86851693 on goods (1), (2)

Action History

Actions
Action Action date Due date Comments
Filed 2016-06-30
Created 2016-07-04
Formalized 2016-07-08
Search Recorded 2017-02-14
Examiner's First Report 2017-02-14 2017-08-14
Extension of Time 2017-08-11 2018-02-14 Request Letter Date: 2017/07/17
Extension of Time Refused 2018-02-15 2018-04-16 Request Letter Date: 2018/02/07
Default Removed 2018-06-04
Correspondence Created 2018-06-04 2018-12-04
Extension of Time 2018-12-06 2019-06-04 Request Letter Date: 2018/11/29
Extension of Time 2019-06-04 2019-12-04 Request Letter Date: 2019/05/15
Correspondence Created 2019-09-05 2020-03-05
Agent Name Changed 2019-09-11
Correspondence Created 2020-01-17 2020-07-17
Correspondence Created 2020-04-16 2020-10-16
Note to file 2020-09-15 Amend the address of the applicant as per correspondence dated May 20, 2020.
Approval Notice Sent 2020-09-21 APPROVED BY PROGRAM EX200M1
Approved 2020-09-21 APPROVED BY PROGRAM EX200M1
Advertised 2020-10-14 Vol.67 Issue 3442
Note to file 2020-11-05 Changes made to the statement of goods as per correspondence of October 30, 2020.
Registration Fee Notice Sent 2021-01-06 2021-07-06
Registration Pending 2021-01-06
Registered 2021-01-13 2031-01-13
Agent Changed 2026-04-21 Transferred From: 5679 To: 59
Date modified: